Literatur
McCullough L, Arora S (2004) Diagnosis and treatment of hypothermia. Am Fam Physician 70: 2325–2332
Umpierrez GE, Woo W, Hogopian WA, Isaacs SP, Palmer JP, Gaur LR, Nepom GT, Clark WS, Mixon PS, Kitabichi AE (1999) Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 22: 1517–1523
Charfen MA, Fernandez-Frackelton M (2005) Diabetic ketoacidosis. Emerg Med Clin North Am 23: 609–628
Fishbein HPP (1995) Acute metabolic complications in diabetes. In: Diabetes in America National Diabetes Data Group, National Institutes of Health, pp 283–291 (NIH publ no.: 95–1468)
Ellemann K, Soerensen JN, Pedersen L, Edsberg B, Anderson OO (1984) Epidemiologiy and treatment of diabetic ketoacidosis in a community population. Diabetes Care 7: 528–532
Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM; American Diabetes Association (2004) Hyperglycemic crises in diabetes. Diabetes care 27 [Suppl 1]: 94–102
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32: 1335–1343
Fulop M, Rosenblatt A, Kreitzer SM, Gerstenhaber B (1975) Hyperosmolar nature of diabetic coma. Diabetes 24: 594–599
Nyenwe EA, Razavi LN, Kitabchi AE, Khan AN, Wan JY (2010) Acidosis: the prime determinant of depressed sensorium in diabetic ketoacidosis. Diabetes Care 33: 1837–1839
Mitchell JH, Wildenthal K, Johnson RL Jr (1972) The effects of acid-base disturbances on cardiovascular and pulmonary function. Kidney Int 1: 375–389
Daugirdas JT, Kronfol NO, Tzamaloukas AH, Ing TS (1989) Hyperosmolar coma: cellular dehydration and the serum sodium concentration. Ann Intern Med 110: 855–857
Reichel A, Rietzsch H, Köhler HJ, Pfützner A, Gudat U, Schulze J (1998) Cessation of insulin infusion at night-time during CSII-therapy: Comparison of regular human insulin and insulin lispro. Exp Clin Endo Diab 106: 168–172
Brandt KR, Miles JM (1988) Relationship between severity of hyperglycemia and metabolic acidosis in diabetic ketoacidosis. Mayo Clin Proc 63: 1071–1074
Lebovits HE (1995) Diabetic ketoacidosis. Lancet 345: 767
Gamblin GT, Ashburn RW, Kemp DG, et al (1986) Diabetic ketoacidosis presenting with a normal anion gap. Am J Med 80: 756–760
Wilson FJ (2010) In the clinic: diabetic ketoacidosis. Ann Intern Med 152: ITC1–16
Slovis CM, Mork VG, Slovis RJ, Bain RP (1987) Diabetic ketoacidosis and infection: leucocyte count and differential as early predictors of serious infection. Am J Emerg Med 5: 1–5
Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24: 131–153
Jalili M (2010) Hypoglycemia. In: Tintinalli JE, Stapczinski JS, Cline DM, Ma OJ, Cydulka RK, Meckler GD (eds) A Comprehensive Study Guide. Tintinalli's Emergency Medicine. www.accessmedicine.com
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
MacLeod KM, Hepburn DA, Frier BM (1993) Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 10: 238–245
Cryer PE (2002) Hypoglycemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45: 937–948
Cryer PE, Davis SN, Shamoon H (2003) Hypoglycemia in diabetes. Diabetes Care 26: 1902–1912
Cryer PE (1997) Hypoglycemia. Pathophysiology, diagnosis and treatment. New York, Oxford Univ Press
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) The UKPDS Rsearch Group: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes: prospective observational study. BMJ 321: 405–412
Khaw K-T, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N (2001) Glycated haemoglobin, diabetes and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322: 15–18
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Service FJ; Endocrine Society (2009) Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 94: 709–728
Towler DA, Havlin CE, Craft S, Cryer P (1993) Mechanisms of awareness of hypoglycemia: perception of neurogenic (cholinergic) rather than neuroglycopenic symptoms. Diabetes 42: 1791–1798
Ponto KA, Matheis N, Kahaly GJ (2010) Diagnostik und Differenzialtherapie der Hyperthyreose. Med Welt 61: 20–25
Cryer PE (2008) Glucose homeostasis and hypoglycaemia. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams Textbook of Endocrinology. Saunders Elsevier, Philadelphia PA, pp 1503–1533
Mc Aulay V, Deary IJ, Frier BM (2001) Symptoms of hypoglycaemia in people with diabetes. Diabet Med 18: 690–705
Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV (1988) Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37: 901–907
Mitrakou A, Fanelli C, Veneman T, Perriello G, Calderone S, Platanisiotis D, Rambotti A, Raptis S, Brunetti P, Cryer P (1993) Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med 329: 834–839
Gama R, Anderson NR, Marks V (2000) Glucose meter hypoglycaemia: often a non-disease. Ann Clin Biochem 37: 731–732
Theofilogiannakos EK, Giannakoulas G, Ziakas A, Karvounis HI, Styliadis IH (2010) Pseudohypoglycemia in a patient with the Eisenmenger syndrome. Ann Intern Med 152(6): 407–408
Wiethop BV, Cryer PE (1993) Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 16: 1131–1136
Karger S, Führer D (2008) Thyroid storm-thyrotoxic crisis: an update. DMW 133: 479
Franklyn JA (1994) The management of hyperthyroidism. N Engl J Med 330: 1731
Wartofsky L (2005) Thyrotoxic storm. In: Braverman LE, Utiger RE (eds) Werner's and Ingbar's The Thyroid: A fundamental and clinical text. Philadelphia, PA: Lippincott Williams and Wilkins, pp 665–694
Sherman SI, Simonson L, Ladenson PW (1996) Clinical and socioeconomic predispositions to complicated thyrotoxicosis: a predictable and preventable syndrome. Am J Med 101: 192–198
Silva JE (2003) The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med 139: 205–213
Klein I, Danzi S (2007) Thyroid diseases and the heart. Circulation 116: 1725–1736
Mohr-Kahaly S, Kahaly G, Meyer J (1996) Cardiovascular involvement in thyroid disease. Z Kardiol 85: 219–231
Schott M, Seißler J, Scherbaum W (2006) Diagnostik bei autoimmunen Schilddrüsenerkrankungen. LaboratoriumsMedizin 30: 254–257
Burch HB, Wartofsky L (1993) Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 22: 263–277
Migneco A, Ojetti V, Testa A, De Lorenzo A, Gentiloni Silveri N (2005) Management of thyrotoxic crisis. Eur Rev Med Pharmacol Sci 9: 69–74
Das G, Krieger M (1969) Treatment of thyrotoxic storm with intravenous administration of popranolol. Ann Intern Med 70: 985–988
Herrmann J (1978) Neue Aspekte in der Therapie der thyreotoxischen Krise. DMW 103: 166–174
Dluhy RG (2005) The adrenal cortex in thyrotoxicosis. In: Braverman LE, Utiger RD (eds) Werner's and Ingbar's The Thyroid: A fundamental and clinical text. Philadelphia: Lippincott, Williams and Wilkins, pp 602–603
Nicoloff JT, Lofresti JS (1993) Myxedema coma. A form of decompensated hypothyroidism. Endo Metab Clin North Am 22: 279–290
Zierhut S, Girlich C (2004) Die thyreotoxische Krise und das Myxodemkoma. Intensivmed 41: 573–582
Beynon J, Akhtar S, Kearney T (2008) Predictors of outcome in myxoedema coma. Crit Care 12: 111
Myers Adler S, Wartofsky L (2008) Myxedema Coma. Contemporary Endocrinology. In: Van den Berghe G (ed) Acute cause to consequence. Humana Press, New York, NY, pp 29–44
Tunbridge W, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 7: 481–93
Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN (1996) Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. BMJ 313: 539–544
Wartofsky L (2006) Myxedema coma. Endocrinol Metab Clin North Am 35: 687–698
Fliers E, Wiersinga WM (2003) Myxedema coma. Rev Endocr Metab Disorders 4: 137–141
Nadkarni PJ, Sharma M, Zinsmeister B, Wartofsky L, Burman KD (2008) Thyrotoxicosis-induced ventricular arrhythmias. Thyroid 18: 1111–1114
Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar D, Seghers A, Cosnard G, Melin J, Daumerie C (2001) Cerebral blood flow and glucose metabolism in hypothyroidism: A positron emission tomography study. J Clin Endocrinol Metab 86: 3864–3870
O'Reilly DS (2000) Thyroid function tests-time for a reassessment. BMJ 320: 1332–1334
Van den Berghe G (2000) Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 143: 1–13
Schrier RW (2008) Vasopressin and Aquaphorin 2 (AQP2) in clinical disorders of water homeostasis. Semin Nephrol 28: 289–296
Hlad CJ Jr, Bricker NS (1954) Renal function and I131 clearance in hyperthyroidism and myxedema. J Clin Endocrinol Metab 14: 1539–1550
Zanjani ED, Banisadre M (1979) Hormonal stimulation of erythropoietin production and erythropoisis in anephric sheep fetuses. J Clin Invest 64: 1181–1187
Mathes DD (1998) Treatment of myxedema coma for emergency surgery. Anesth Analg 8: 450–451
Strewler GJ, et al (2005) Hypercalcemia of malignancy and parathyroid hormone-related protein. In: Clark O, Duk Q-Y, Kebebene E (eds) Textbook of Endocrine Surgery. Philadelphia, PA. Elsevier Saunders 536–542
Myers L, Hays H (1991) Myxedema coma. Crit Care Clin 7: 43–56
Cronin CS, Reeve TS, Robinson B, et al (1996) Primary hyperparathyroidism in childhood and adolescence. J Paediatr Child Health 32: 397–399
Solimando DA (2001) Overview of hypercalcemia of malignancy. Am J Health Syst Pharm 58 [Suppl 3]: 4–7
Lumachi F, Brunello A, Roma A, Basso U (2009) Cancer-induced hypercalcemia. Anticancer Res 5: 1551–1555
Ziegler R (2001) Hypercalcemic crisis. J Am Soc Nephrol 12: 3–9
Baraniskin A, Schmiegel W, Schroers R (2009) Notfälle in der Hämatologie und Onkologie. Dtsch Med Wochenschr 134: 1879–1888
Büttner R, Langgartner J (2004) Die hyperkalziämische Krise. Intensivmed 41: 406–416
Bilezikian JP, Silverber SJ (2000) Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disorders 1: 237–245
Mallette LE, Bilezikian JP, Heath DA, Aurbach GD (1974) Primary hyperparathyroidism: clinical and biochemical features. Medicine (Baltimore) 53: 127–146
Arlt W (2009) The approach to the adult with newly diagnosed adrenal insufficiency. Clin Endocrinol Metabolism 94: 1059–1067
Fitzpatrick LA, Bilezikian JP (1987) Acute primary hyperparathyroidism. Am J Med 82: 275–282
Le Grand SB, Leskuski D, Zama I (2008) Narrative review: Furosemide for hypercalcemia: An unproven yet common practice. Ann Intern Med Practice 149: 259–263
Addison T (1855) On the constitutional and local effects of diseases of the supra-renal capsules. London: Samuel Highley
Oelkers W (1989) Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321: 492–496
Neufeld M, Meclaren NK, Blizzard RM (1981) Two types of autoimmune Addison's disease associated with different poly-glandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60: 355–362
Soul S (1999) Addison's disease in Africa: a teaching hospital experience. Clin Endocrinol 50: 115–120
Kong MF, Jeffcoate W (1994) Eighty-six cases of Addison's disease. Clin Endocrinol 41: 757–761
Zelissen PM (1994) Addison patients in the Netherlands: medical report of the survey. The Hague: Dutch Addison Society
Reincke M, Allolio B, Wurth G, Winkelmann W (1993) The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotrophin-releasing hormone. J Clin Endocrinol Metab 77: 151–156
Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL (1991) Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 72: 39–45
Manger WM, Gifford RW Jr, Hoffman BB (1985) Pheochromocytoma: a clinical and experimental overview. Curr Probl Cancer 9: 1–89
Bryant J, Farmer J, Kessler LJ, Townsend RR, Nathanson KL (2003) Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95: 1196–1204
Sutton MG, Sheps SG, Lie JT (1981) Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56: 354–360
Knüttgen D, Wappler F (2008) Anästhesie bei Phäochromozytom. Besonderheiten, mögliche Komplikationen der medikamentösen Strategien. Anasthesiol Intensivmed Notfallmed Schmerzther 1: 20–27
Bravo E (2002) Pheochromocytoma. Cardiol Rev 10: 44–50
Wenger U (2009) Hypertensive Krise. Praxis 98: 115–121
Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366: 665–675
Chen H, Sippel RS, O'Dorisio MS, Vinik AI, Lloyd RV, Pacak K (2010) The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors. Pheochromocytoma, paraganglioma, and medullary thyroid carcinoma. Pancreas 39: 775–783
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wohlschläger-Krenn, E., Luger, A. & Gessl, A. Endokrinologische Notfälle. Wiener Klin. Wochenschr. Educ. 5, 137–164 (2010). https://doi.org/10.1007/s11812-010-0076-2
Issue Date:
DOI: https://doi.org/10.1007/s11812-010-0076-2